CLO23-051: Real-World Use of Neratinib in Patients With HER2-Positive Early-Stage Breast Cancer Following Prior Ado-Trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade With Pertuzumab Plus Trastuzumab
作者
Kelly McCann,Nina Oestreicher,Christopher G. Rowan,Gregory A. Vidal
"CLO23-051: Real-World Use of Neratinib in Patients With HER2-Positive Early-Stage Breast Cancer Following Prior Ado-Trastuzumab Emtansine (T-DM1) or Dual HER2 Blockade With Pertuzumab Plus Trastuzumab" published on 31 Mar 2023 by National Comprehensive Cancer Network.
PDF的下载单位、IP信息已删除
(2025-6-4)
cocodu
Nole
cdercder
东方元语
xing_xing
Kao
张欢馨
张开心
OK
aajhajkahna
aaaa
若一
乐空思
学术文献互助
七听
Criminology34
牧青
dde
yjh123
v0id
皖公网安备34019202002308
